Skip to main content
//empty //empty
Coronavirus information
Coronavirus information
The Zero Canada Project provides resources to help you manage your health, your finances and your family life as Canada reopens.
Visit the hub

An NHS employee collects a sample at a testing centre near the Crown and Anchor pub following a spike in cases of the COVID-19 to visitors of the pub in Stone, Britain, July 30, 2020.

CARL RECINE/Reuters

Millions of COVID-19 tests able to detect the virus within 90 minutes will be rolled out to British hospitals, care homes and laboratories to boost capacity in the coming months, the country’s health minister said on Monday.

They will comprise 5.8 million tests using DNA and 450,000 swab tests. Neither will need to be administered by a health professional, said Matt Hancock.

“The fact these tests can detect flu as well as COVID-19 will be hugely beneficial as we head into winter, so patients can follow the right advice to protect themselves and others,” he said.

Story continues below advertisement

Separately, the publicly-funded National Health Service said it would be offering “COVID-friendly” treatments to cancer patients, including drugs that do not have a big impact on the immune system.

Britain’s health care system has come under severe strain during peaks in the country’s COVID-19 outbreak, which has killed more than 46,000 people, the fourth highest toll in the world, according to a Reuters tally collated on Sunday.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies